Clinical trials in Liege – page 33

648 clinical trials in Liege, Belgium across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Liege at a glance

648

clinical trials

Research sites5

Quick filters

648 trials in Liege

Open in trial search

Breast cancer+2

Not recruiting

Study of 89Zr-trastuzumab PET/CT imaging and trastuzumab emtansine treatment in patients with advanced HER2-positive breast cancer

Registered drugNo placebo

Study of 89Zr-trastuzumab PET/CT imaging and trastuzumab emtansine treatment in patients with advanced HER2-positive breast cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Trastuzumab
Sponsor:Institut Jules Bordet

Contact Research Centre

Sickle cell disease

Not recruiting

Study on the Effects of Tebapivat and AG-946 in Patients with Sickle Cell Disease

Investigational

Study on the Effects of Tebapivat and AG-946 in Patients with Sickle Cell Disease

Investigational

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:AG-946 phosphate
Sponsor:Agios Pharmaceuticals Inc.

Contact Research Centre

Multifocal motor neuropathy

Not recruiting

Study comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy

Registered drug

Study comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Empasiprubart
Sponsor:Argenx

Contact Research Centre

Coronavirus infection

Not recruiting

Study on COVID-19 Prevention Using Sipavibart and Cilgavimab for Patients with Weakened Immune Systems

Registered drug

Study on COVID-19 Prevention Using Sipavibart and Cilgavimab for Patients with Weakened Immune Systems

Registered drug

Belgium

Participants:0–17 years · 18–64 years · 65+ years · Healthy volunteers
Substances:Cilgavimab
Sponsor:AstraZeneca AB

Contact Research Centre

Chronic graft versus host disease

Not recruiting

Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

InvestigationalNo placebo

Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

InvestigationalNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Axatilimab
Sponsor:Incyte Corp.

Contact Research Centre

Obesity+1

Not recruiting

Study on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes

Investigational

Study on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide
Sponsor:Amgen Inc.

Contact Research Centre

Chronic inflammatory demyelinating polyradiculoneuropathy

Not recruiting

Study on the Safety and Effects of NVG-2089 for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

InvestigationalNo placebo

Study on the Safety and Effects of NVG-2089 for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:NVG-2089
Sponsor:Nuvig Therapeutics Inc.

Contact Research Centre

Breast cancer+1

Not recruiting

Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Registered drugNo placebo

Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Abemaciclib
Sponsor:Pfizer Inc.

Contact Research Centre

Sickle cell anaemia with crisis

Not recruiting

Study on the Safety and Effectiveness of CSL889 for Adults and Adolescents with Sickle Cell Disease During Painful Crises

Investigational

Study on the Safety and Effectiveness of CSL889 for Adults and Adolescents with Sickle Cell Disease During Painful Crises

Investigational

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Hemopexin, human
Sponsor:CSL Behring LLC

Contact Research Centre

Oesophageal adenocarcinoma

Not recruiting

Study on ABBV-400, Fluorouracil, Leucovorin, and Budigalimab for Advanced or Metastatic Stomach and Esophageal Cancer Patients

Registered drugNo placebo

Study on ABBV-400, Fluorouracil, Leucovorin, and Budigalimab for Advanced or Metastatic Stomach and Esophageal Cancer Patients

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Budigalimab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Ocular myasthenia

Not recruiting

Study on the Effectiveness and Safety of Efgartigimod in Adults with Ocular Myasthenia Gravis

Registered drug

Study on the Effectiveness and Safety of Efgartigimod in Adults with Ocular Myasthenia Gravis

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa
Sponsor:Argenx

Contact Research Centre

Acute kidney injury

Not recruiting

Study of GDC-8264 compared to placebo for preventing kidney injury in patients at risk of acute kidney injury after heart surgery

Investigational

Study of GDC-8264 compared to placebo for preventing kidney injury in patients at risk of acute kidney injury after heart surgery

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:RO7288817
Sponsor:Genentech Inc.

Contact Research Centre

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Liege

What the registry says about research in the country

01 Infectious Disease Research

Groundbreaking vaccine trials focusing on chickenpox, cytomegalovirus, and respiratory syncytial virus. These studies aim to evaluate immune responses and develop effective prevention strategies for vulnerable populations.

Varicella vaccine safety in children
CMV prevention in young adults
RSV protection in transplant recipients

02 Oncology Studies

Advanced research into various cancer treatments, particularly focusing on lung cancer and gastric cancer. Trials evaluate novel therapeutic combinations and targeted treatments for improved patient outcomes.

Non-small cell lung cancer therapies
Hematological cancer treatments
Advanced breast cancer interventions

03 Autoimmune Conditions

Innovative trials investigating treatments for inflammatory bowel disease, psoriasis, and chronic inflammatory conditions. Research focuses on developing targeted therapies and understanding disease mechanisms.

IBD pain management studies
Plaque psoriasis treatments
Inflammatory polyneuropathy therapies

Back to Belgium All countries